Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.
Strickland KC, Nesline MK, Previs RA, Ko H, Cooper M, Rushton JR, Wallen ZD, Pabla S, Conroy JM, Sausen M, Saini KS, Cantini L, Jensen TJ, Caveney BJ, Eisenberg M, Severson EA, Ramkissoon S. Strickland KC, et al. Among authors: cooper m. Front Oncol. 2024 Oct 31;14:1445668. doi: 10.3389/fonc.2024.1445668. eCollection 2024. Front Oncol. 2024. PMID: 39544293 Free PMC article.
FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
Sharaf R, Pavlick DC, Frampton GM, Cooper M, Jenkins J, Danziger N, Haberberger J, Alexander BM, Cloughesy T, Yong WH, Liau LM, Nghiemphu PL, Ji M, Lai A, Ramkissoon SH, Albacker LA. Sharaf R, et al. Among authors: cooper m. Neurooncol Adv. 2021 Feb 4;3(1):vdab017. doi: 10.1093/noajnl/vdab017. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33778493 Free PMC article.
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer.
Nesline MK, Subbiah V, Previs RA, Strickland KC, Ko H, DePietro P, Biorn MD, Cooper M, Wu N, Conroy J, Pabla S, Zhang S, Wallen ZD, Sathyan P, Saini K, Eisenberg M, Caveney B, Severson EA, Ramkissoon S. Nesline MK, et al. Among authors: cooper m. Oncol Ther. 2024 Jun;12(2):329-343. doi: 10.1007/s40487-024-00270-x. Epub 2024 Mar 19. Oncol Ther. 2024. PMID: 38502426 Free PMC article.
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.
Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Ko HC, et al. Among authors: cooper m. Breast Cancer (Dove Med Press). 2024 Aug 23;16:483-495. doi: 10.2147/BCTT.S476394. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39192887 Free PMC article.
Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers.
Previs RA, Strickland KC, Wallen Z, Ko H, Green M, Cooper M, Lyon E, Biorn M, Armetta J, Quarles R, Watson CH, Ring K, Klein JL, Caveney B, Severson EA, Ramkissoon S. Previs RA, et al. Among authors: cooper m. Gynecol Oncol. 2024 Dec 3;192:102-110. doi: 10.1016/j.ygyno.2024.11.010. Online ahead of print. Gynecol Oncol. 2024. PMID: 39631181 Free article.
Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
Sharaf R, Pavlick DC, Frampton GM, Cooper M, Jenkins J, Danziger N, Haberberger J, Alexander BM, Cloughesy T, Yong WH, Liau LM, Nghiemphu PL, Ji M, Lai A, Ramkissoon SH, Albacker LA. Sharaf R, et al. Among authors: cooper m. Neurooncol Adv. 2021 Jun 22;3(1):vdab059. doi: 10.1093/noajnl/vdab059. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34169283 Free PMC article.
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Schneider BP, Jiang G, Ballinger TJ, Shen F, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Hancock BA, Kassem N, Helft P, O'Neil B, Storniolo AMV, Badve S, Miller KD, Radovich M. Schneider BP, et al. Among authors: cooper me. J Clin Oncol. 2022 Feb 1;40(4):345-355. doi: 10.1200/JCO.21.01657. Epub 2021 Dec 15. J Clin Oncol. 2022. PMID: 34910554 Clinical Trial.
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Shen F, Storniolo AMV, Badve S, Ballinger TJ, Chang CL, Zhong Y, Savran C, Miller KD, Schneider BP. Radovich M, et al. Among authors: cooper me. JAMA Oncol. 2020 Sep 1;6(9):1410-1415. doi: 10.1001/jamaoncol.2020.2295. JAMA Oncol. 2020. PMID: 32644110 Free PMC article. Clinical Trial.
5,740 results